Home › Funds › Royce & Associates › BLFS
Royce & Associates position in BLFS
BIOLIFE SOLUTIONS INC · Health Care
Latest position (Q2 2026)623.88K sh
Reported value held$17.62M
Portfolio Weight0.14%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 187.16K | $7.92M | New |
| Q4 2021 | 57.30K | $2.14M | Reduce |
| Q2 2022 | 21.80K | $301.00K | New |
| Q3 2022 | 21.60K | $491.00K | Reduce |
| Q3 2023 | 242.78K | $3.35M | New |
| Q4 2023 | 871.60K | $14.16M | Add |
| Q1 2024 | 515.21K | $9.56M | Reduce |
| Q2 2024 | 912.65K | $19.56M | Add |
| Q3 2024 | 825.13K | $20.66M | Reduce |
| Q4 2024 | 777.28K | $20.18M | Reduce |
| Q1 2025 | 860.74K | $19.66M | Add |
| Q2 2025 | 521.80K | $11.24M | Reduce |
| Q3 2025 | 471.93K | $12.04M | Reduce |
| Q4 2025 | 417.09K | $10.09M | Reduce |
| Q1 2026 | 584.01K | $11.14M | Add |
| Q2 2026 | 623.88K | $17.62M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BLFS
- BlackRock Inc 6.38M sh · $180.05M · Q2 2026
- Casdin Capital 4.66M sh · $131.46M · Q2 2026
- Vanguard Group 3.09M sh · $74.65M · Q4 2025
- Invesco Ltd 2.24M sh · $63.27M · Q2 2026
- Geode Capital Management 1.09M sh · $30.70M · Q2 2026
- MFS Investment Management 1.08M sh · $30.48M · Q2 2026
- Fidelity Management & Research (FMR) 993.11K sh · $28.05M · Q2 2026
- Bank of America Corp 950.16K sh · $26.83M · Q2 2026
- UBS Group AG 832.14K sh · $23.50M · Q2 2026
- Millennium Management 675.66K sh · $19.08M · Q2 2026
- Goldman Sachs Group 569.08K sh · $16.07M · Q2 2026